Comparison of the PACE 2 assay, two amplification assays, and Clearview EIA for detection of Chlamydia trachomatis in female endocervical and urine specimens.
about
Prevalence of Chlamydia trachomatis infection among women in a Middle Eastern communityExternal quality assessment program for Chlamydia trachomatis diagnostic testing by nucleic acid amplification assaysComparison of a polymer conjugate-enhanced enzyme immunoassay to ligase chain reaction for diagnosis of Chlamydia trachomatis in endocervical swabs.Effect of endocervical specimen adequacy on ligase chain reaction detection of Chlamydia trachomatis.Low prevalence of Chlamydia trachomatis infection in non-urban pregnant women in Vellore, S. India.Comparison of STD prevalences in the Mwanza, Rakai, and Masaka trial populations: the role of selection bias and diagnostic errors.Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.Diagnosis and assessment of trachoma.Reasons for testing women for genital Chlamydia trachomatis infection in the Calgary region.New point of care Chlamydia Rapid Test--bridging the gap between diagnosis and treatment: performance evaluation study.Prevalence of Chlamydia trachomatis infection among low- and high-risk Filipino women and performance of Chlamydia rapid tests in resource-limited settings.Clinic-based evaluation of Clearview Chlamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at high risk in China.Clinic-based evaluation of a rapid point-of-care test for detection of Chlamydia trachomatis in specimens from sex workers in Escuintla, GuatemalaCost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting.
P2860
Q24796288-1991ECA6-57EC-4331-A668-DB1B19040653Q33966100-742F889B-1E20-49E8-9D8D-0946C6695204Q33972686-EDC9A695-8FEB-4C7D-A9ED-3EA266CDA3D1Q33973847-C6B71329-CBDB-4BFE-BA73-D5E17BD113CEQ34261506-C0F62775-652D-4BEC-BED1-9C5924EDCAA8Q35530476-52E22EE4-77DE-46FC-A7C7-C7E581A32607Q35763113-3AE87639-4C06-4AC2-A200-5FCC7977BCA2Q35920659-B7A395E2-8954-4574-BD01-CC8F4B484308Q36170683-35D74689-A11C-4A7D-AB39-38E665E30C0EQ36248523-BFFE390E-518C-4906-B9FB-ED0A9F2DE47FQ36314501-1A55E597-D22D-4E3F-B909-8FC761801F9AQ36928838-56E53540-CFDF-41E8-87E2-7048E0BE8331Q37099616-1E893757-B1DA-4EAC-A292-DF88EE02684EQ37264849-D0413DB2-3252-4856-96AA-4479C1DAC560
P2860
Comparison of the PACE 2 assay, two amplification assays, and Clearview EIA for detection of Chlamydia trachomatis in female endocervical and urine specimens.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Comparison of the PACE 2 assay ...... ocervical and urine specimens.
@ast
Comparison of the PACE 2 assay ...... ocervical and urine specimens.
@en
type
label
Comparison of the PACE 2 assay ...... ocervical and urine specimens.
@ast
Comparison of the PACE 2 assay ...... ocervical and urine specimens.
@en
prefLabel
Comparison of the PACE 2 assay ...... ocervical and urine specimens.
@ast
Comparison of the PACE 2 assay ...... ocervical and urine specimens.
@en
P2093
P2860
P1476
Comparison of the PACE 2 assay ...... docervical and urine specimens
@en
P2093
I Thorneycroft
T L Lauderdale
P2860
P304
P407
P577
1999-07-01T00:00:00Z